BPA Call 36C25024A0005-36C25025N0092

Award Date 1/1/25
Potential Completion Date 12/31/25
Potential Value $38K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Veterans Integrated Service Network 10 (VISN 10), a civilian agency within the Department of Veterans Affairs, to Ortho-Clinical Diagnostics, Inc. The $84,912.63 firm-fixed-price contract provides an immunohematology analyzer system, training, support, and associated reagents through September 30, 2023. This award is a call against a larger $249,000 Blanket Purchase Agreement (BPA) that runs through December 2028. Ortho-Clinical Diagnostics, Inc....
This federal contract award is for ORTHOVISION CPT, a critical analyzer and laboratory equipment contract issued by the Veterans Integrated Service Network 10 (VISN 10), a component of the U.S. Department of Veterans Affairs. The contract has a ceiling value of $54,985.04 and was awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is a Blanket Purchase Agreement (BPA) call under the GSA Federal Supply Schedule 66-III for Critical Analyzers and...
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency under the Department of Veterans Affairs, to Ortho-Clinical Diagnostics, Inc. The contract is for the provision of a Trandusion Analyzer and Associated Products from the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule. The contract has a ceiling value of $186,357.95 and a completion date of April 8, 2027. Ortho-Clinical Diagnostics is a...
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 9 of the U.S. Department of Veterans Affairs to Ortho-Clinical Diagnostics, Inc. for immunochemistry emergency extension services. The contract has a ceiling value of $93,171.31 and a period of performance ending on February 26, 2020. It was awarded under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule, with no set-aside designation. Ortho-Clinical Diagnostics, Inc. is...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, for the provision of analytical laboratory instrumentation for blood bank cost-per-test requirements. The contract has a ceiling value of $123,450.52 and an ultimate completion date of September 30, 2025. The contract is a delivery order under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) schedule contract and utilizes a firm fixed-price pricing...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for Transfusion Medicine Testing Service. The contract has a ceiling value of $999,455.56 and a period of performance ending on May 19, 2029. The contract is not set aside and was awarded under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule. Ortho-Clinical Diagnostics specializes in providing advanced diagnostic...
This is a firm fixed price BPA call contract awarded by the Veterans Integrated Service Network 9 (VISN 9) of the U.S. Department of Veterans Affairs to Ortho-Clinical Diagnostics, Inc. The contract is for the exercise of Option Year #4 for medical equipment and services, with a ceiling value of $85,819.08 and a completion date of March 31, 2017. The contract vehicle is a General Services Administration (GSA) Federal Supply Schedule contract for Critical Analyzers, Laboratory (FSS-66-III)....
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 10 of the U.S. Department of Veterans Affairs to Ortho-Clinical Diagnostics, Inc. The contract is for $3,406,355.50 and has an ultimate completion date of September 26, 2029. The contract is for chemistry requirements and is placed under the Critical Analyzers, Laboratory (FSS-66-III) master schedule. Ortho-Clinical Diagnostics, Inc. is a medical equipment manufacturing company that provides a...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 10 awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Ortho-Clinical Diagnostics Inc. on October 1, 2021 for an Immunohematology Analyzer system, training, support, and associated reagents. The contract has a potential value of $106,216.67 and a completion date of September 30, 2022. Ortho-Clinical Diagnostics Inc. is a medical equipment manufacturer that...
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 23 (VISN 23), a component of the U.S. Department of Veterans Affairs, to Ortho-Clinical Diagnostics, Inc. The contract is for laboratory equipment and supplies under the Critical Analyzers, Laboratory (FSS-66-III) federal supply schedule, with a ceiling value of $194,994.66 and a completion date of July 19, 2017. The contract does not have a set-aside designation. Ortho-Clinical Diagnostics is a...

This is a firm fixed price contract awarded by the Veterans Integrated Service Network 10 (VISN 10), which is part of the U.S. Department of Veterans Affairs, to Ortho-Clinical Diagnostics, Inc. for an immunohematology analyzer CPT system. The contract has a ceiling value of $37,677.09 and a period of performance ending on December 31, 2025. This award is made under the Critical Analyzers, Laboratory (FSS-66-III) master GSA schedule contract. Ortho-Clinical Diagnostics, Inc. is a for-profit medical equipment manufacturer that has previously provided diagnostic solutions, reagents, and testing services to various federal agencies. The contract does not utilize a set-aside designation.

Generated 12/6/24, 9:27 AM